This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Patrick AR, Avorn J, Choudhry NK.The Cost-Effectiveness of Genotype-Guided Warfarin Dosing for Patients with Atrial Fibrillation. 25th International Conference on Pharmacoepidemiology and Therapeutic Risk Management: abstr. 053, 16 Aug 2009. Available from: URL: https://www.pharmacoepi.org/meetings/25thconf
Rights and permissions
About this article
Cite this article
Worth of genotyping for warfarin therapy unclear. Pharmacoecon. Outcomes News 588, 8 (2009). https://doi.org/10.2165/00151234-200905880-00019
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200905880-00019